Onduo joint venture Verily-Sanofi has signed a deal with Orpyx Medical Technologies to offer the latter firm's SurroSense Rx system to select members of Onduo ’s personalised diabetes management platform in later 2016 . Orpyx Medical Technologies 's SurroSense Rx system comprises a thin sensor, which is placed inside a patient's shoe, and sends an alert to a connected smartwatch if it detects dangerous pressure levels.
Verily-Sanofi joint venture Onduo has signed a deal with Orpyx Medical Technologies to offer the latter firm's SurroSense Rx system to select members of Onduo’s personalised diabetes management platform in 2019. Orpyx's SurroSense Rx system comprises a thin sensor, which is placed inside a patient's shoe, and sends an alert to a connected smartwatch if it detects dangerous pressure levels.